KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xylem (XYL) EBT Margin (2016 - 2025)

Xylem has reported EBT Margin over the past 16 years, most recently at 15.35% for Q4 2025.

  • Quarterly results put EBT Margin at 15.35% for Q4 2025, down 127.0% from a year ago — trailing twelve months through Dec 2025 was 13.07% (up 38.0% YoY), and the annual figure for FY2025 was 13.07%, up 38.0%.
  • EBT Margin for Q4 2025 was 15.35% at Xylem, up from 13.1% in the prior quarter.
  • Over the last five years, EBT Margin for XYL hit a ceiling of 16.62% in Q4 2024 and a floor of 1.23% in Q3 2022.
  • Median EBT Margin over the past 5 years was 10.09% (2021), compared with a mean of 10.37%.
  • Biggest five-year swings in EBT Margin: tumbled -928bps in 2022 and later soared 768bps in 2023.
  • Xylem's EBT Margin stood at 9.52% in 2021, then skyrocketed by 32bps to 12.55% in 2022, then decreased by -21bps to 9.92% in 2023, then soared by 68bps to 16.62% in 2024, then dropped by -8bps to 15.35% in 2025.
  • The last three reported values for EBT Margin were 15.35% (Q4 2025), 13.1% (Q3 2025), and 12.99% (Q2 2025) per Business Quant data.